Vai al contenuto

Interazioni tra farmaci

Acalabrutinib + Eptifibatide

Gravità: Maggiore

Acalabrutinib and Eptifibatide: major interaction.

Ultimo aggiornamento

Per operatori sanitari — solo a scopo di riferimento. Questa pagina è una sintesi breve, non è un parere medico e non sostituisce il RCP ufficiale né il giudizio clinico. Verificare sempre prima di prescrivere o dispensare.

Il contenuto clinico di questa pagina è disponibile solo in inglese.

Sintesi

Acalabrutinib impairs platelet function through BTK inhibition and is associated with bruising and hemorrhage. Adding eptifibatide, a glycoprotein IIb/IIIa inhibitor, increases the likelihood of significant bleeding.

Cosa significa questa interazione in parole semplici

Acalabrutinib and Eptifibatide can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for.

Acalabrutinib belongs to Oncology; Eptifibatide belongs to Cardiovascular.

Livello di evidenza: Moderate

Perché avviene

Additive impairment of platelet function via BTK inhibition and glycoprotein IIb/IIIa receptor blockade.

Cosa fare

Avoid combining where possible; if eptifibatide is essential, monitor closely for bleeding and hemoglobin. Consider holding acalabrutinib around invasive procedures.

Cosa chiedere al farmacista

  • Does the benefit of taking both outweigh the risk in my case?
  • Do I need any blood test, ECG or other check while on both?
  • What early warning signs should I watch for, and what should I do if they appear?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Per gli utenti Pro+

Sblocca la pagina completa

Crei un account e avvii una prova di Pro+ per sbloccare le indicazioni complete sulla gestione di Acalabrutinib e Eptifibatide, le note aggiuntive, il dettaglio delle evidenze e il controllo delle interazioni per un'intera prescrizione.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Provi Pro+ gratis per 14 giorni sul web. Nessuna carta.

Domande frequenti

Can I take Acalabrutinib with Eptifibatide?

MediHelp rates the interaction as major. Acalabrutinib and Eptifibatide can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for. Acalabrutinib impairs platelet function through BTK inhibition and is associated with bruising and hemorrhage. Adding eptifibatide, a glycoprotein IIb/IIIa inhibitor, increases the likelihood of significant bleeding.

How serious is the interaction between Acalabrutinib and Eptifibatide?

MediHelp rates it major, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Avoid combining where possible; if eptifibatide is essential, monitor closely for bleeding and hemoglobin. Consider holding acalabrutinib around invasive procedures.

What other medicines interact with Eptifibatide?

MediHelp also lists interactions of Eptifibatide with, for example, Abrocitinib, Acetylsalicylic acid, Antithrombin alfa. The full list is on the Eptifibatide page.

Monografie complete, posologie e verifica delle interazioni nell'app MediHelp

Apra il riferimento completo, verifichi le interazioni tra più farmaci e usi gli strumenti di posologia nell'app MediHelp.

Sfoglia dalla A alla Z · Interazioni tra farmaci

Scarica l'app Accedi